User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Advanced Oncotherapy Investors - AVO

Advanced Oncotherapy Investors - AVO

Buy
Sell
Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Advanced Oncotherapy Plc AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 36.00 08:00:00
Open Price Low Price High Price Close Price Previous Close
36.00 36.00 36.00 36.00 36.00
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Top Investor Posts

DateSubject
13/2/2021
18:32
pj84: robbiekeane thanks, just listened to the podcast with the AVO CEO which is just over 17 mins and very informative and would recommend, a good listen for both long term investors and those new trying to understand what AVO does and the potential.
13/2/2021
14:05
robbiekeane: Nicolas Serandour interview with UK Investor hTTps://ukinvestormagazine.co.uk/advanced-oncotherapy-democratising-proton-beam-therapy-in-cancer-treatment/
26/11/2020
10:52
igbertsponk: or it could meander about until the larger investors decided what price to put the next raft of dosh in at to keep the Board in clover.
18/8/2020
17:04
sea and sky: well anyone who's been an early investor (like my poor self) has the patience of Jobe!
28/2/2020
08:17
twirl: hardman are paid to come up with these blue sky reports. There have been several over the decade - often prior to fund raising. This IMHO is a real gamble not because of the technology but the Chinese involvement which will lead to funds shortage - chinese bail out - directors parachute - investors shafted.
11/2/2020
07:13
waterloo01: Nice of them to let investors know that the agreement with Circle had 'lapsed'. Profit sharing? No numbers attached.
03/6/2019
08:29
baner: AVO now looks like a real target for one of the major players in this segment. a potential unicorn stand alone, i guess 100p will be needed to take this off current investors. looks increasingly good! "only" negative is that they are likely to require more funds if they are to complete the development fully on their own. high risk still, however upside tremendous.
22/2/2019
17:53
daijavu: I hope you are right but, in my experience, the BoD do not feel much loyalty to their small private investors.
14/12/2018
11:05
metis20: From LSE board 3rd Dec "Harley Street, the scaffolding is coming down at the front, still plenty to do at the back but progressing well." and from 10th October RNS - Work is progressing at Daresbury Laboratory to build and prepare the test facility ready for the installation and assembly of the full LIGHT system from later this year. Some of the components of the LIGHT system have already been delivered onsite. The Science and Technology Facilities Council ("STFC") and AVO are working closely to ensure that the building work is on track to allow the installation of the LIGHT system to start next month in order to be ready for full-energy testing next year. Https://www.investegate.co.uk/advanced-oncotherapy--avo-/rns/technological-update/201810100700034752D/ Https://www.hardmanandco.com/wp-content/uploads/2018/10/AVO-Technical-update-16-October-2018.pdf To date during 2018, AVO has raised ca.£40m of cash from its new commercial partner, Yantai CIPU, and other investors, which has enabled the company to clear all its debts, provide working capital and bring additional stability. Further capital will be required, which could come from a number of sources. However, AVO, on the back of its continuous and successful operational progress, has greater flexibility now with its improved and clean balance sheet.
12/12/2017
07:34
daijavu: baner I have rarely met anyone as capable of misunderstanding other investors comments as you. There is no shame in pointing out that the BoD has a chequered history and have been prone to giving out misinformation to investors in the past. In November 2014, AVO gave a presentation and published a schedule that clearly stated that LIGHT would be fully developed by mid 2016 and that the first patients would be treated by mid 2017. They maintained that position until early 2017, long after it had become unlikely that it could be true and in the face of increasing questions from long term and very loyal investors who had all invested for the same reasons that you have. If that were they only black mark in the history of the AVO BoD it would be bad enough but it is not. They have a whole history of misinforming investors on financial and contractual matters In Spring 2017, AVO issued the present schedule and removed all traces of the earlier presentation and schedule from the record. As for China, They have had previous similar agreements, including one that was announced to the world by the Governments of China and the UK at a major international presentation in China. They were awarded three contracts with promises of at least four more. They had Sinophi as their agent. Sinophi paid AVO large sums of money on account. The entire Chinese market appeared open to AVO. There was great excitement. AVO raised large amounts from investors on the back of it. The share price was heading to the sky. It reached 400p and seemed unstoppable. It all fizzled out because AVO could not deliver. All the Chinese contracts were cancelled by the Chinese Government, Sinophi cancelled their agency contract with AVO and demanded their money back. AVO refused to repay the cash but eventually caved in and paid it all back. It was a disaster for all AVO investors. I was lucky to get out at 53p with my shirt on my back. Others were not so lucky. I have no doubts about the value of LIGHT and the enormous benefits it should provide to the world but the BoD is another kettle of fish altogether. At the very least, they are inept and appalling businessmen who have no regard for the interests of the shareholders. I fully expect LIGHT to take over the world. It is a fantastic piece of kit but it will not necessarily be owned by AVO when it does and you will not necessarily make any money out of it.
ADVFN Advertorial
Your Recent History
LSE
AVO
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210508 22:30:58